Results 61 to 70 of about 10,365 (241)

Experimental proliferative vitreoretinopathy

Yeungnam University Journal of Medicine, 1991
The authors performed experimental study to produce proliferative vitreoretinopathy by intravitreal injection of homologous fibroblasts in pigmented rabbits. Twenty four eyes of 12 rabbits were divided into control and experimental groups. In experimental group, the eyes were pretreated with expanding gas, perfluoropropane for the vitrectomy.
Duk Kee Hahn, Bong Hwan Lee, Young Hoon Park   +2 more
openaire   +2 more sources

Ozurdex(R) (a slow-release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial [PDF]

, 2013
Proliferative vitreoretinopathy (PVR) is the commonest cause of late anatomical failure in rhegmatogenous retinal detachment. Visual and anatomical outcomes remain poor despite advances in vitreoretinal surgical techniques with reported primary failure ...
Banerjee, PJ, Bunce, C, Charteris, DG
core  

Staining and peeling of the internal limiting membrane using a fluorescent dye (Rhodamine 6 G) [PDF]

, 2008
Aim: To assess whether low concentrations of a fluorescent dye such as Rhodamine 6G would help the unaided human eye visualise the vitreous and the internal limiting membrane (ILM) under standard halogen illumination.Material/methods: The UV/Vis ...
Haritoglou, Christos, Kampik, Anselm, Kreutzer, Thomas, Langhals, Heinz, May, C. A., Tadayoni, R., Thaler, S.   +6 more
core   +1 more source

Phenotypic Expansion of Knobloch Syndrome Type 2 in an Individual With a De Novo PAK2 Variant

American Journal of Medical Genetics Part A, Volume 197, Issue 6, June 2025.
ABSTRACT P21‐activated kinase 2 (PAK2) is a serine/threonine kinase essential for a variety of cellular processes including signal transduction, cellular survival, proliferation, and migration. A recent report proposed monoallelic PAK2 variants cause Knobloch syndrome type 2 (KNO2)—a developmental disorder primarily characterized by ocular anomalies ...
Elizabeth A. Werren, Louisa Kalsner, Jessica M. Ewald, Michael Peracchio, Cameron King, Purva Vats, Peter A. Audano, Peter N. Robinson, Mark D. Adams, Melissa A. Kelly, Adam P. Matson   +10 more
wiley   +1 more source

Intravitreal injection of bevacizumab in primary vitrectomy to decrease the rate of retinal redetachment: A randomized pilot study

Journal of Ophthalmic & Vision Research, 2016
Purpose: To evaluate the effect of intravitreal bevacizumab (IVB) as a surgical adjunct in prevention of proliferative vitreoretinopathy (PVR) after retinal detachment surgery. Methods: In this controlled, randomized pilot study, 27 patients with primary
Adib Tousi, Hossein Hasanpour, Masoud Soheilian   +2 more
doaj   +1 more source

A Retrospective Clinical Study of the Etiology and Post-operative Visual Outcome of Rhegmatogenous Retinal Detachment [PDF]

Journal of Clinical and Diagnostic Research, 2014
Aim: To study the etiology of rhegmatogenous retinal detachment and visual outcome after retinal detachment surgery. Materials and methods: Retrospective study conducted at the tertiary eye care hospital over a period of one year.
Achyut N Pandey, Anil Kakde
doaj   +1 more source

Lipid peroxidation in proliferative vitreoretinopathies [PDF]

Eye, 1999
To study the lipid hydroperoxide activity in vasoproliferative and fibroproliferative retinal disorders.Vitreous body samples from patients undergoing vitrectomy because of proliferative vitreoretinopathy (PVR; n = 12) or proliferative diabetic retinopathy (PDR; n = 15), and rhegmatogenous retinal detachment/macular hole/epiretinal membranes as the ...
P Marco, C Verdejo, Jaime Renau-Piqueras, Maria D Pinazo-Duran   +3 more
openaire   +3 more sources

The effect of axial length on pseudophakic retinal detachment

Acta Ophthalmologica, Volume 103, Issue 2, Page 146-151, March 2025.
Abstract Purpose The purpose of the study was to analyse the surgical management and outcome regarding axial length in the population affected by pseudophakic retinal detachment (PRD) 2015–2020. Method The patients included were from an observational cohort study of patients undergoing cataract surgery in the region of Skåne during 2015–2017. Data were
Joakim Thylefors, Rafi Sheikh, Gunnar Jakobsson   +2 more
wiley   +1 more source

Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy [PDF]

, 2020
12 páginasLa vitreorretinopatía proliferativa (VPR) es la principal causa de fracaso en la cirugía de desprendimiento de retina. A pesar de los avances significativos en cirugía vitreorretiniana, aún carece de un tratamiento médico profiláctico o ...
Amarnani, Dhanesh, Delgado-Tirado, Santiago, Eliott, Dean, Greene, Whitney A., Miller, John B., Rossin, Elizabeth J., Zhao, Guannan   +6 more
core   +1 more source

Clinical and genetic characteristics and natural history of Finnish families with familial exudative vitreoretinopathy due to pathogenic FZD4 variants

Acta Ophthalmologica, Volume 103, Issue 2, Page 152-161, March 2025.
Abstract Purpose To report clinical and genetic characteristics of familial exudative vitreoretinopathy (FEVR) in the Finnish population. Methods Detailed clinical and genetic data of 35 individuals with heterozygous pathogenic variants in FZD4 were gathered and analysed.
Laura Lähteenoja, Tapani Palosaari, Timo Tiirikka, Maria Haanpää, Jukka Moilanen, Aura Falck, Elisa Rahikkala   +6 more
wiley   +1 more source